Jnba Financial Advisors Gilead Sciences, Inc. Transaction History

Jnba Financial Advisors

$980 Million
Q3 2024

A detailed history of Jnba Financial Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jnba Financial Advisors holds 4,484 shares of GILD stock, worth $415,128. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,484

Previous 4,584 2.18%

Holding current value

$415,128

Previous $314,000 19.43%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$66.59 - $83.99 $6,659 - $8,399	-100 Reduced 2.18%	4,484 $375,000
Q1 2024 Apr 26, 2024	BUY	$71.58 - $87.29 $6,800 - $8,292	95 Added 2.12%	4,584 $335,000
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $7,327 - $8,309	100 Added 2.28%	4,489 $363,000
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $369 - $403	5 Added 0.11%	4,389 $328,000
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $4,256 - $4,855	-56 Reduced 1.26%	4,384 $337,000
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $7,112 - $8,103	-92 Reduced 2.03%	4,440 $368,000
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $72,291 - $103,785	-1,160 Reduced 20.38%	4,532 $389,000
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $17,862 - $20,403	-300 Reduced 5.01%	5,692 $351,000
Q2 2022 Jul 22, 2022	SELL	$57.72 - $65.01 $5,772 - $6,501	-100 Reduced 1.64%	5,992 $370,000
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $23,168 - $29,032	-400 Reduced 6.16%	6,092 $362,000
Q4 2021 Feb 03, 2022	SELL	$64.88 - $73.64 $1,686 - $1,914	-26 Reduced 0.4%	6,492 $471,000
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $31,735 - $34,675	-500 Reduced 7.12%	6,518 $449,000
Q1 2021 May 03, 2021	SELL	$60.0 - $68.46 $60 - $68	-1 Reduced 0.01%	7,018 $454,000
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $11,273 - $12,845	-199 Reduced 2.76%	7,019 $409,000
Q2 2020 Jul 24, 2020	SELL	$72.34 - $84.0 $2,170 - $2,520	-30 Reduced 0.41%	7,218 $555,000
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $37,578 - $48,132	600 Added 9.03%	7,248 $542,000
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $7,764 - $8,540	126 Added 1.93%	6,648 $432,000
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $22,816 - $25,185	365 Added 5.93%	6,522 $413,000
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $12,374 - $13,876	200 Added 3.36%	6,157 $416,000
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $2.58 Million - $3.37 Million	-42,648 Reduced 87.74%	5,957 $373,000
Q3 2018 Nov 01, 2018	BUY	$71.28 - $78.92 $2.95 Million - $3.27 Million	41,398 Added 574.41%	48,605 $3.75 Million
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $38,928 - $45,408	-600 Reduced 7.69%	7,207 $511,000
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $37,353 - $43,848	-525 Reduced 6.3%	7,807 $559,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,332	8,332 $590,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Gilead Sciences, Inc. Transaction History